HD-tDCS for Adolescent Bipolar Depression Targeting S1
RecruitingNCT07246044Phase: NAStarted 2025-09-16
Summary
This randomized, double-blind, sham-controlled clinical trial aims to evaluate the efficacy and underlying biological mechanisms of HD-tDCS targeting the primary somatosensory cortex in adolescents wi
Eligibility
Sex
ALL
Min Age
12 Years
Max Age
18 Years
Locations
Affiliated Nanjing Brain Hospital, Nanjing Medical UniversitNanjing, Jiangsu, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07246044